Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
34.64
-0.07 (-0.20%)
Aug 31, 2026, 4:00 PM EDT - Market closed

Roivant Sciences Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
25,02119,8257,2008,4945,5973,419
Market Cap Growth
205.59%175.36%-15.23%51.75%63.72%580.90%
Enterprise Value
21,28616,1092,5002,8245,0211,886
Last Close Price
34.6427.7010.0910.547.384.94

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
---1.95--
PS Ratio
3322.002400.11247.81259.64177.5261.84
PB Ratio
5.923.751.391.323.481.66
P/TBV Ratio
5.914.381.541.425.532.06

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
2826.121950.2286.0586.33159.2534.11

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.020.020.020.010.300.14
Net Debt / Equity Ratio
-0.76-0.79-0.92-1.00-0.74-0.86
Net Debt / EBITDA Ratio
2.753.284.468.501.512.13
Net Debt / FCF Ratio
4.555.525.678.401.402.56
Asset Turnover
0.000.000.010.010.010.02
Quick Ratio
13.6215.2632.7124.356.2911.21
Current Ratio
16.7218.3733.4725.246.6011.64
Return on Equity (ROE)
-8.52%-7.59%-12.54%112.87%-48.46%-44.82%
Return on Assets (ROA)
-16.48%-14.35%-10.73%-10.14%-20.33%-20.26%
Return on Invested Capital (ROIC)
-118.82%-169.69%-532.64%-369.64%-232.11%-312.50%
Return on Capital Employed (ROCE)
-27.10%-23.60%-20.60%-11.20%-38.20%-34.90%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-1.06%-1.51%-2.39%51.20%-18.03%-24.72%
FCF Yield
-3.28%-3.83%-11.72%-9.03%-15.29%-20.33%
Buyback Yield / Dilution
1.06%4.35%12.71%-16.59%-6.43%-6.30%
SEC Filings: 10-K · 10-Q